Immune cells that keep the brain free of debris but also contribute to inflammation are the likely culprits behind the concentration and memory problems that sometimes follow one type of chemotherapy, a new study in mice suggests.
Immune cells that keep the brain free of debris but also contribute to inflammation are the likely culprits behind the concentration and memory problems that sometimes follow one type of chemotherapy, a new study in mice suggests.
NIH grantees report results of first multi-site randomized trial comparing the two diets.
A new study may reveal part of the reason why conservatives are more likely than liberals to reject some COVID-19 health measures: They see boundaries as restrictions.
Machine learning approach automates behavior analysis, outperforms human assessment in animal models of epilepsy.
A more mystical and insightful psychedelic drug experience may be linked to an enduring reduction in anxiety and depression symptoms, according to a new study.
Nuclear physicists have found a way to peer inside the deepest recesses of atomic nuclei, according to a new study.
The Ohio State University alumnus Ratmir Timashev visited the university’s Columbus campus on Feb. 16 to announce a historic $110 million gift from the Timashev Family Foundation to establish the Center for Software Innovation. During his visit, Timashev participated in a fireside chat with Max M. Fisher College of Business students and shared insights about software entrepreneurship, product management, sales and marketing – priorities that the newly established center will advance.
NIH-supported study demonstrates injectable ART may improve outcomes in underserved patients
Newly discovered gene helps some yeast endure toxins and can help scientists understand toxin resistance.
NIH-funded clinical study points to potential new therapy for upper-limb paralysis.